Fierce Biotech July 12, 2024
Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here at the end of each week.
Veteran Pfizer R&D leader takes a bow
After leading Pfizer’s R&D unit through the pandemic, Chief Scientific Officer Mikael Dolsten, M.D., Ph.D., is heading out.
The New York pharma giant announced the departure Tuesday, at the same time launching a public search for a successor.
“I want to thank Mikael for his incredible contributions, not only to Pfizer and the scientific community but to the millions of patients he has impacted over the years. Mikael is a...